The Oncology Institute, Inc. (TOI)

NASDAQ: TOI · Real-Time Price · USD

2.610

-0.120 (-4.40%)

At close: Mar 10, 2026, 4:00 PM EDT

2.647

+0.037 (1.43%)

After-hours: Mar 10, 2026, 4:52 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Patient Services	204.88M	213.50M	166.79M	124.07M	116.82M
Patient Services Growth	-4.04%	28.01%	34.42%	6.21%	19.66%
Dispensary	179.92M	103.84M	79.34M	72.55M	63.89M
Dispensary Growth	73.27%	30.87%	9.36%	13.55%	27.90%
Clinical Trials & Other	8.61M	6.90M	6.36M	6.38M	6.81M
Clinical Trials & Other Growth	24.83%	8.58%	-0.38%	-6.30%	-13.01%
Total	393.41M	324.24M	252.48M	203.00M	187.52M
Total Growth	21.33%	28.42%	24.37%	8.26%	20.66%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	393.41M	324.24M	252.48M	203.00M	187.52M
United States Growth	21.33%	28.42%	24.37%	8.26%	20.66%
Total	393.41M	324.24M	252.48M	203.00M	187.52M
Total Growth	21.33%	28.42%	24.37%	8.26%	20.66%

Source: S&P Global Market Intelligence.